Substipharm acquires IMOJEV® from Sanofi
LMT Avocats advised Substipharm, a privately held pharmaceutical group, in the acquisition of the Japanese Encephalitis vaccine IMOJEV® from Sanofi. Our Team was headed by Cristian Rawlins and Antoine Lemétais with the active involvement of Charline Mathé and Grégoire Tonnelle.